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Abstract
Background: To explain why rates of colorectal cancer (CRC) screening including fecal occult
blood testing (FOBT), flexible sigmoidoscopy (FS), colonoscopy (CS), and barium enema (BE), are
low, this study assessed determinants of CRC screening from medical records.
Methods: Data were abstracted from patients aged ≥64 years selected from each clinician from
30 diverse primary care practices (n = 981). Measurements included the rates of annual FOBT, ever
receiving FOBT, ever receiving FS/CS/BE under a combination variable, endoscopy/barium enema
(EBE).
Results: Over five years, 8% had received annual FOBT, 53% had ever received FOBT and 22%
had ever received EBE. Annual FOBT was negatively associated with female gender, odds ratio
(OR) = .23; 95% confidence interval = .12–.44 and positively associated with routinely receiving
influenza vaccine, OR = 2.55 (1.45–4.47); and more office visits: 3 to <5 visits/year, OR = 2.78
(1.41–5.51), and ≥5 visits/year, OR = 3.35 (1.52-7.42). Ever receiving EBE was negatively associated
with age ≥75 years, OR = .66 (.46–.95); being widowed, OR = .59 (.38–.92); and positively
associated with more office visits: 3 to <5 visits/year, OR = 1.83 (1.18–2.82) and ≥5 visits/year, OR
= 2.01 (1.14–3.55).
Conclusion: Overall CRC screening rates were low, but were related to the number of primary
care office visits. FOBT was related to immunization status, suggesting the possible benefit of linking
these preventive services.
Background
Colorectal cancer (CRC) is the second leading cause of
cancer-related deaths in the United States, causing an esti-
mated 56,808 annual deaths in 2001 [1]. SEER data show
that CRC death rates were 20 per 100,000 in 2001 which
is substantially higher than the Healthy People 2010 tar-
get of 13.9 deaths per 100,000 [2]. Furthermore, racial dis-
parity occurred with CRC mortality rates at 24.5 per
100,000 for African Americans versus 17.1 per 100,000
for whites.
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Healthy People 2010 set screening rate goals for adults
aged 50 years and older of 50% for having received a fecal
occult blood test (FOBT) within the preceding 2 years and
50% for ever receiving a sigmoidoscopy. Despite these
goals and the availability of national recommendations
for screening, [3,4] CRC screening rates are low. According
to the 2000 National Health Interview Survey, the overall
rates of CRC screening among adults age 50 and older in
the US were 17.3% for FOBT in the last year, and 30% for
lower endoscopy [5].
The objective of this study was to quantify determinants
of CRC screening derived from medical records of patients
in a variety of geographic, socioeconomic and practice set-
tings, including 30 rural, inner-city, Veterans' Affairs (VA)
and urban/suburban primary care practices in western
and central Pennsylvania. Demographics, number of
office visits, strata, type of visit (acute care, chronic care or
preventive) and other factors were evaluated for associa-
tion with CRC screening, towards the goal of suggesting
interventions to raise rates. The perspective of medical
record review complements those of patient and provider
surveys and focus groups about barriers to CRC screening
[6-13].
Methods
Medical record and survey data from two studies were
combined for this study. Methods of sample selection and
recruitment were similar for both studies and have been
published [14,15]. Thus, they are combined in the
descriptions that follow.
Subjects
A random sample of approximately 22 patients was
selected from practices of each of the clinicians in four
strata: 8 rural practices in a network, 12 urban/suburban
practices from two networks, 7 inner-city practices (3 in a
network and 4 independent federally qualified health
centers), and 3 VA practices. Requested inclusion criteria
were age ≥66 years, to allow for a year of potential access
for preventive services that begin at age 65, and an office
visit after September 30, 1998. Patients who were home-
less, residing in nursing homes, or not currently living in
western or central Pennsylvania, and those who were deaf,
had severe psychosis or dementia were excluded. This
project was approved by the Institutional Review Board of
the University of Pittsburgh.
An introductory letter from the principal investigator,
along with consent forms and an endorsement letter from
the patient's clinician on practice letterhead, was sent to
1800 patients. Potential participants were offered a $20
honorarium to complete an interview and agree to medi-
cal record review. The response rates for the surveys were
72%-73% for a total of 1245 [14,15]. Of these, 1002 con-
sented for medical record review (80%), and 981 records
were usable with sufficient data for analysis.
Patient survey
Most results of the patient survey (which dealt with
immunizations) have been reported elsewhere and the
information from the survey that is reported here relates
to demographics and health habits such as smoking [14-
16].
Medical record data collection
Data were collected for all visits (approximately 13,000)
dated January 1, 1997 through December 31, 2001. The
practices had different methods of recording cancer
screening, including handwritten notes, health mainte-
nance flow sheets and electronic medical records. A cus-
tomized electronic spreadsheet was created for direct data
entry using a laptop computer. A code book was devel-
oped to guide the medical record reviewers. Trained
research assistants collected the following data: stratum,
sex, age, presence of a health maintenance flow sheet, date
of first visit to practice, and for each visit, date, type, name
of clinician seen, use of cancer detection tests, purpose of
cancer detection tests (screening or diagnostic), and
immunizations given. All visits (excluding laboratory-
only visits) during the look-back period (up to 60
months) were recorded, then collated to create a summary
data base with total visits, total acute (e.g., viral infection),
chronic (e.g., hypertension follow-up) and preventive
(e.g., annual physical) visits, number of visits with the
study-assigned primary care provider (PCP), demographic
variables, cancer detection tests, and immunizations
given. Recommendations to screen are reported, but only
cancer screenings actually performed were used in the
analyses. Rates were adjusted for number of months avail-
able for record review.
Statistical analyses
The original clustered sampling schemes for the studies
were no longer applicable to this sample because the data
came from two studies and 20% of the sample did not
consent to medical record review. Therefore, analyses
were conducted without stratification. Trend analysis was
performed to determine whether there were differences
among the mean number of various types of visits. Fre-
quencies and bivariate analyses using Chi-Square tests or,
if the cell size was small, Fisher's exact tests were calcu-
lated. Outcome variables were the rate of annual FOBT,
ever receiving FOBT, and ever receiving FS, CS, or BE
under a combination variable called endoscopy/barium
enema (EBE), during the study period.
Multivariate logistic regression was used to determine fac-
tors related to CRC screening. In the multivariate models,
all variables associated in bivariate analyses with theBMC Health Services Research 2006, 6:116 http://www.biomedcentral.com/1472-6963/6/116
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dependent variable at the P ≤ 0.10 level were included as
independent variables, provided cell sizes were adequate.
Also included were any variables specified a priori (i.e.,
age, race). No interaction terms were found to be signifi-
cant, therefore, they were not included in the models. All
statistical analyses were performed using SAS 8.2 statisti-
cal software (SAS Inc, Cary, North Carolina). Statistical
significance was set at P ≤ 0.05.
Table 1: Demographics, Characteristics of Visits to the Primary Care Office, and Preventive Services Usage
Characteristic N = 981 (%)
Demographics and Health Habits from Patient Survey
Age
64–74 years 61


























Characteristics of Visits to Primary Care Office from Medical Records
Visits/year to primary care officea (n)
< 2 35
2 – 3 26
3 – 4 26
≥5 13
Visits to identified primary care providerb
0 – 25% 8
26 – 50% 12
51 – 75% 19
76 – 100% 62
Preventive Health Service Usage from Medical Records
Annual influenza vaccine (up to 4 seasons) 17
Pneumococcal polysaccharide vaccine 64
Tetanus toxoid 33




aVisits/year was a continuous variable which was grouped as <2, 2-<3, 3-<5 and ≥5, but given simplified labels in the Table.
bVisits to identified primary care provider was a continuous variable which was grouped as 0-<26%, 26%-<50%, 50%-<75% and ≥75%, but given 
simplified labels in the Table.BMC Health Services Research 2006, 6:116 http://www.biomedcentral.com/1472-6963/6/116
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Results
Characteristics of the study population
The sample was primarily aged 64–74 years, Caucasian,
and lower-income (Table 1). One-half were female, half
were currently married and half were previous smokers.
Over one-third (35%) had fewer than two visits to the pri-
mary care office each year (Table 1); most visits were to
the provider designated by the practice as the primary care
provider. The average total number of visits per year dur-
ing the study period was 3.0 ± 2.2, with 1.4 ± 1.9 acute
care visits, 8.0 ± 6.1 chronic care visits and 1.0 ± 1.7 pre-
ventive visits. Participants had significantly fewer mean
acute care visits than chronic and preventive visits (P =
0.029) and significantly higher mean chronic care visits
than preventive care visits (P < 0.001). Although most
patients (97%) were seen for chronic care visits, less than
half (41%) had preventive care visits and 57% had acute
care visits (P = 0.03). Over one-half of the women had
received a mammogram within the last year and two-
thirds had received pneumococcal polysaccharide vacci-
nation (Table 1). Patient medical records indicated that
60% of patients (n = 589) had received one or more types
of CRC screening during the study period.
Frequency of FOBT ranged from 0 to 9 during the study
period. Only 7.5% (74/981) of patients used FOBT
screening at a rate of ≥1 FOBT per year and 53% had ever
used FOBT during the study period. Most patients
(80.3%) did not have a discussion of FOBT with their pro-
viders, with the remainder having ≤ 2.2 discussions per
year. Four percent of patients refused FOBT per year. Most
(83%) FOBT were undertaken for screening purposes.
Frequency of BE ranged from 0–2, sigmoidoscopy ranged
from 0–3 and colonoscopy ranged from 0–4 during the
study period. Only 22% (219/981) had EBE recorded
within the study period, with 21 (2%) having one or more
BEs, 78 (8%) having one or more sigmoidoscopies and
166 (17%) having one or more colonoscopies (individu-
als may have had more than one type of test). Per year,
discussions of EBE were recorded for 24% of patients and
4% of patients refused EBE. Sigmoidoscopy or colonos-
copy was primarily performed (68%) for diagnostic pur-
poses.
Association of colon cancer screening with other factors
In bivariate analyses, receiving annual FOBT was associ-
ated with being male, being seen at the VA, never having
smoked, receiving annual influenza vaccine and the teta-
nus toxoid (Table 2). Ever receiving FOBT was associated
with being younger, male, married, employed, never hav-
ing smoked, receiving annual influenza vaccine, having
received pneumococcal vaccine and tetanus toxoid, hav-
ing a moderate number of visits, primarily with one's own
provider at an urban/suburban practice. Ever receiving
EBE was associated with being younger, male, married, of
middle to low income, with fewer visits to the PCP.
Multivariate analyses showed that, after controlling for
other variables, a significantly higher rate of annual FOBT
was found for those who were male, had more frequent
office visits and those who received annual influenza vac-
cine (Table 3). Ever receiving FOBT was significantly more
common in those 64–74 years of age, those who were
employed, those receiving care at the VA, those with 3 to
<5 visits/year, and in those vaccinated against pneumo-
coccus and tetanus. Multivariate analyses showed that
EBE was significantly less common among those 75 years
of age and older compared with younger patients; among
the widowed, compared with the married; and more com-
mon in those with more frequent office visits.
Discussion
U.S. national rates of CRC screening are low. Based on
patient survey data, FOBT within the last year was 19.8%
in 1997, 20.6% in 1999 and 23.5% in 2001. In the same
three years, lower endoscopy within the last 5 years was
reported to be 29.9%, 33.3% and 38.7%, respectively [7].
Although the measurement was different, the present
study also found low rates based on primary care office
medical record reviews over several years: 7.5% for ≥1
FOBT per year, 53% for ever receiving FOBT and 22% for
ever receiving EBE. Interestingly, there was no association
between race and CRC screening as has been reported
elsewhere [1].
In this study, FOBT was the primary CRC screening meas-
ure, as 83% of tests were performed for screening pur-
poses. In multivariate analyses, the most important
variables associated with FOBT screening were being seen
in a VA practice, being employed, having more frequent
office visits, annual influenza and other vaccination
receipt. EBE in this study was primarily diagnostic in
nature, but was associated with being younger, not being
widowed and having more frequent office visits. Others
have reported an association between the number of vis-
its, particularly preventive care visits, and screening rates.
In one study, having a health maintenance visit was
strongly predictive of receiving FOBT, flexible sigmoidos-
copy, digital rectal exam and PSA [17] and in another,
regardless of age, patients who scheduled a preventive
visit were more likely to have received preventive services
such as mammograms, FOBT and flexible sigmoidoscopy
[18].
The Task Force on Community Preventive Services system-
atically reviewed the literature and recommended a
number of interventions to raise rates of CRC screening,
including client reminders and removal of structural bar-






































































































































Table 2: Association of Colon Cancer Screening with Demographics, Characteristics of Visits to the Primary Care Office, and Preventive Services Usage from Medical Records
Characteristic FOBTa <1/year 
(n = 907) %
Annual FOBT 
(n = 74) %
P FOBT never 
(n = 462) %
FOBT ever 
(n = 519) %
P No EBEb 
(n = 762) %
EBE 
(n = 219) %
P
Demographics
Age (ref. = 75 + years)
64–74 years 61 62 0.852 57 65 0.005 59 69 0.007
Race (ref. = African-American)
Caucasian 92 90 0.523 93 91 0.24 92 92 0.921
Gender (ref. = male)
Female 53 23 <.001 60 43 <.001 54 40 <.001
Marital status
Never married 4 7 0.103 5 4 0.03 4 6 <.001
Married 53 65 51 57 51 65
Widowed 34 20 37 28 36 22
Divorced/separated 9 8 7 10 9 7
Education
< High school 30 32 0.512 28 32 0.68 32 25 0.06
Some high school 45 50 47 44 45 46
High school grad/tech school 20 14 20 19 19 21
Some college 5 4 5 5 4 8
Stratum
Rural 19 4 <.001c 24 12 <.001 20 12 0.015
Urban 47 23 47 43 43 52
Veterans' Affairs 19 64 14 30 22 25
Inner city 15 9 15 14 15 11
Employed (ref. = unemployed) 15 15 0.931 12 18 0.025 16 14 0.479
Income level
<$10,000 19 10 0.237 21 17 0.423 20 13 0.02
$10,000–19,999 38 48 39 39 39 38






































































































































≥$40,000 14 12 13 14 12 19
Smoking status
Smoker 11 4 .023c 11 11 0.001 11 11 0.326
Quitter 40 32 45 34 41 35
Never smoker 48 64 44 55 49 54
Characteristics of Visits to Primary Care and Preventive Services Usage from Medical Records
Visits/year to primary care officed
< 2 36 20 <.001 38 32 0.009 37 29 <.001
2 – 3 27 18 27 24 27 21
3 – 4 25 38 21 31 24 34
≥51 2 2 4 1 3 1 2 1 1 1 7
Visits to designated PCPe,f
0 – 25% 8 5 .368c 8 8 0.011 7 10 0.608
26 – 50% 12 14 14 10 12 12
51 – 75% 19 12 15 23 19 20
76 – 100% 61 69 64 60 62 59
Mammography status/time since last 
mammogram
Never 11 12 0.836 15 5 <.001 11 8 0.072
< 1 year 59 65 54 66 57 70
≥1 year 30 24 31 29 32 22
Annual influenza vaccine 16 38 <.001 14 20 0.014 16 21 0.093
Pneumococcal vaccine 63 74 0.093 56 71 <.001 63 69 0.069
Tetanus toxoid within 10 yrs. 32 45 0.025 26 39 <.001 32 36 0.245
aFecal Occult Blood Test
bEndoscopy/Barium Enema
cBy Fisher's Exact Test
dVisits/year was a continuous variable which was grouped as <2, 2-<3, 3-<5 and ≥5, but given simplified labels in the Table.
ePrimary Care Provider
fVisits to identified PCP was a continuous variable which was grouped as 0-<26%, 26%-<50%, 50%-<75% and ≥75%, but given simplified labels in the Table.
Totals may differ from 100% due to rounding
Table 2: Association of Colon Cancer Screening with Demographics, Characteristics of Visits to the Primary Care Office, and Preventive Services Usage from Medical Records (Continued)BMC Health Services Research 2006, 6:116 http://www.biomedcentral.com/1472-6963/6/116
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tions to raise CRC screening rates have found that
organizational change is highly effective and that provider
education; provider reminders, such as health mainte-
nance flow sheets, prevention stickers or stamps, chart
reminders; shared responsibility among staff; patient edu-
cation and reminders, such as patient-held health mainte-
nance cards; and patient financial incentives were also
effective [20-27]. Some of the trials to raise rates involved
either allowing practices to choose their own interven-
tions from a menu or tailoring them to the office culture
and style [26,28].
The VA has a multimodal program for prevention services
including assessment, feedback, incentives, reminders,
computerized tracking and a prevention nurse who oper-
ates under standing orders. Such programs have been
highly successful for vaccinations, [29,30] seem to be suc-
cessful for colon cancer screening as well, as indicated by
our data, and are consistent with recent systematic reviews
to raise rates.
Given the strength of evidence for interventions to raise
rates, the question must be asked why CRC screening rates
remain so low. The idea of competing demands suggests
that patients and physicians bring an implicit agenda of
issues to the primary care visit. Their interaction, comple-
mented by other factors, including visit and health system
factors, results in some issues being addressed but not oth-
ers, which are left for subsequent visits or left unaddressed
[31]. Competing demands have been noted for a number
of preventive services, [31] in fact, another study found
that missed opportunities for vaccination occurred from
38% to 94% of visits, depending on visit type [32].
A barrier to screening may be cost. In the past, patients
have reported concerns about payment for CRC screening
to be a factor preventing their participation [33]. In July
2001, Medicare reimbursement for screening colonos-
copy was approved for persons at average risk for CRC.
Therefore, cost may have been a barrier in this population.
The importance of cost as a patient barrier to CRC screen-
ing should wane. In fact, since these data were collected,
Meissner et al have reported significant increases in self-
reported colonoscopy rates, especially among adults age
65 and older [34].
Access may also be a barrier to CRC screening using
endoscopy. There is currently insufficient capacity to
screen all eligible patients using colonoscopy [35] and
overall costs would increase, despite reduced CRC care
costs [36]. Therefore, FOBT is an important and practical
alternative CRC screening method.
Previous research has shown that productivity incentives
for providers decrease provision of preventive services
such as in-office screenings, [37] because increases in pro-
Table 3: Factors Associated with Colon Cancer Screening by Logistic Regression
Characteristic Annual FOBTa FOBT ever Sigmoidoscopy, Colonoscopy or Barium Enema ever
Age (ref . = 64–74 years)
75 + years .99 (.59 – 1.71) .71 (.53 – .95)* .66 (.46 – .95)*
Gender (ref. = Male)
Female .23 (.12 – .44)* .74 (.53 – 1.02) .74 (.49 – 1.11)
Marital status (ref. = Married)
Never married 1.80 (.64 – 5.07) .84 (.43 – 1.63) 1.13 (.54 – 2.36)
Widowed .84 (.42 – 1.68) .98 (.71 – 1.37) .59 (.38 – .92)*
Divorced/separated .99 (.33 – 3.01) 1.02 (.57 – 1.80) .69 (.33 – 1.44)
Employed (ref. = unemployed) NSc 1.48 (1.00 – 2.20)* NId
Stratum (ref. = Inner city)
Rural N/Ab .70 (.41 – 1.18) 1.03 (.5 – 2.1)
Urban 1.18 (.75 – 1.87) 1.51 (.83 – 2.76)
Veterans' Affairs 2.45 (1.45 – 4.13)* 1.28 (.68 – 2.44)
Clinician visits/year (ref. <2)
2 – <3 1.25 (0.57 – 2.73) 1.17 (0.82 – 1.66) 1.10 (0.69 – 1.74)
3 – <5 2.78 (1.41 – 5.51)* 1.81 (1.23 – 2.60)* 1.83 (1.18 – 2.82)*
≥5 3.35 (1.52 – 7.42)* 1.24 (.77 – 1.98) 2.01 (1.14 – 3.55)*
Annual influenza vaccine 2.55 (1.45 – 4.47)* 1.25 (.85 – 1.84) 1.12 (.72 – 1.74)
Pneumococcal vaccine 1.01 (.56 – 1.82) 1.55 (1.16 – 2.08)* 1.23 (.85 – 1.77)
Tetanus toxoid 1.37 (.81 – 2.33) 1.46 (1.07 – 2.00)* NSc
*P < .05
aFOBT = fecal occult blood test
bN/A = Not included in logistic regression because of small cell sizes
cNS = Not significant in bivariate analyses; not included in logistic regression
dNI = Not included in logistic regression because income was correlated with education |r| = 0.44; P < .001BMC Health Services Research 2006, 6:116 http://www.biomedcentral.com/1472-6963/6/116
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ductivity are often associated with decreases in visit time.
It follows that physicians need to focus on the most press-
ing concerns in the time allotted for either an acute or
chronic care visit. Longer visit times afford the physician
more time to address preventive services such as immuni-
zations, [38] and screenings, suggesting a need for longer
scheduled preventive care visits. Mailed reminders to
patients to schedule such annual visits might result in
increased screening rates.
Potential to link cancer screening and immunization
The association found between CRC screening and immu-
nizations, suggests that annual influenza vaccination
might be a time to encourage cancer screening. There is
considerable overlap in ages for influenza vaccine recom-
mendations, CRC screening, and mammography, [3,4,39]
and one study found higher rates of mammography when
offered to women attending influenza vaccination clinics
[40]. For instance, at an influenza vaccination clinic, a sec-
ond station could be set up to offer FOBT, instructions for
completion and mammography prescriptions to appro-
priate patients, without substantially hindering the vacci-
nation effort. Combining these preventive services would
also be more cost efficient given that one mailed reminder
could potentially replace two or three. A trial of this idea
is warranted.
Strengths and limitations
Over 13,000 visits from almost 1000 medical records in a
diverse cross-section of practice types, socioeconomic and
geographic settings were examined. However, racial repre-
sentation was restricted to primarily two racial groups.
This study is limited by the fact that it represents the per-
spective of medical record review in primary care prac-
tices, thereby missing specialist and hospital records of
CRC screening that patients may have received, but they
were not captured in these data because reports were not
forwarded to the PCP. Because cancer screening was rela-
tively uncommon among this population, it was neces-
sary to combine procedures (FS, CS and BE) in order to
assess factors related to invasive CRC screening. This pro-
hibited examining factors related to specific screening
procedures. While these data were collected several years
ago, there has been no significant change in self-reported
FOBT rates [34]. Influenza vaccination rate was rather low
for several reasons including the fact that 1) many individ-
uals in this geographic area can and do, receive influenza
vaccine at community sites rather than at the PCP office;
2) the look-back period included the 2000–01 influenza
season in which there was a delay in receipt of vaccine by
many PCP offices; and 3) one would expect the rate of
receipt of influenza vaccine every year over several years to
be lower than rate of receipt during any one year.
Conclusion
Based on the review of medical records in the primary care
office, CRC screening rates were low. The number of visits
to the primary care office was associated with both nonin-
vasive and invasive CRC screening tests and immuniza-
tion status was associated with FOBT screening. This
suggests that linking preventive services with similar rec-
ommendations, such as annual influenza vaccination and
FOBT screening, may improve uptake.
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